skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Refinado por: Nome da Publicação: Blood remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Stopping bleeding is not enough to FIX hemarthropathy
Stopping bleeding is not enough to FIX hemarthropathy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Stopping bleeding is not enough to FIX hemarthropathy

Arruda, Valder R.

Blood, 2017-04, Vol.129 (15), p.2048-2049 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
12
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1

Arruda, Valder R. ; Schuettrumpf, Joerg ; Herzog, Roland W. ; Nichols, Timothy C. ; Robinson, Nancy ; Lotfi, Yasmin ; Mingozzi, Federico ; Xiao, Weidong ; Couto, Linda B. ; High, Katherine A.

Blood, 2004-01, Vol.103 (1), p.85-92 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
13
Recombinant canine B-domain–deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model
Recombinant canine B-domain–deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model
Material Type:
Artigo 		Adicionar ao Meu Espaço

Recombinant canine B-domain–deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A model

Sabatino, Denise E. ; Freguia, Christian Furlan ; Toso, Raffaella ; Santos, Andrey ; Merricks, Elizabeth P. ; Kazazian, Haig H. ; Nichols, Timothy C. ; Camire, Rodney M. ; Arruda, Valder R.

Blood, 2009-11, Vol.114 (20), p.4562-4565 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
14
AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice
AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice
Material Type:
Artigo 		Adicionar ao Meu Espaço

AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice

Crudele, Julie M. ; Finn, Jonathan D. ; Siner, Joshua I. ; Martin, Nicholas B. ; Niemeyer, Glenn P. ; Zhou, Shangzhen ; Mingozzi, Federico ; Lothrop, Clinton D. ; Arruda, Valder R.

Blood, 2015-03, Vol.125 (10), p.1553-1561 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
15
Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model
Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model
Material Type:
Artigo 		Adicionar ao Meu Espaço

Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model

Arruda, Valder R. ; Stedman, Hansell H. ; Nichols, Timothy C. ; Haskins, Mark E. ; Nicholson, Matthew ; Herzog, Roland W. ; Couto, Linda B. ; High, Katherine A.

Blood, 2005-05, Vol.105 (9), p.3458-3464 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
16
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy

Mount, Jane D. ; Herzog, Roland W. ; Tillson, D. Michael ; Goodman, Susan A. ; Robinson, Nancy ; McCleland, Mark L. ; Bellinger, Dwight ; Nichols, Timothy C. ; Arruda, Valder R. ; Lothrop, Clinton D. ; High, Katherine A.

Blood, 2002-04, Vol.99 (8), p.2670-2676 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
17
Posttranslational modifications of recombinant myotube-synthesized human factor IX
Posttranslational modifications of recombinant myotube-synthesized human factor IX
Material Type:
Artigo 		Adicionar ao Meu Espaço

Posttranslational modifications of recombinant myotube-synthesized human factor IX

Arruda, Valder R. ; Hagstrom, James N. ; Deitch, Jeffrey ; Heiman-Patterson, Terry ; Camire, Rodney M. ; Chu, Kirk ; Fields, Paul A. ; Herzog, Roland W. ; Couto, Linda B. ; Larson, Peter J. ; High, Katherine A.

Blood, 2001-01, Vol.97 (1), p.130-138 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
18
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy

Niemeyer, Glenn P. ; Herzog, Roland W. ; Mount, Jane ; Arruda, Valder R. ; Tillson, D. Michael ; Hathcock, John ; van Ginkel, Frederik W. ; High, Katherine A. ; Lothrop, Clinton D.

Blood, 2009-01, Vol.113 (4), p.797-806 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
19
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy

Finn, Jonathan D. ; Nichols, Timothy C. ; Svoronos, Nikolaos ; Merricks, Elizabeth P. ; Bellenger, Dwight A. ; Zhou, Shangshen ; Simioni, Paolo ; High, Katherine A. ; Arruda, Valder R.

Blood, 2012-11, Vol.120 (23), p.4521-4523 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
20
Factor IX variants improve gene therapy efficacy for hemophilia B
Factor IX variants improve gene therapy efficacy for hemophilia B
Material Type:
Artigo 		Adicionar ao Meu Espaço

Factor IX variants improve gene therapy efficacy for hemophilia B

Schuettrumpf, Joerg ; Herzog, Roland W. ; Schlachterman, Alexander ; Kaufhold, Antje ; Stafford, Darrel W. ; Arruda, Valder R.

Blood, 2005-03, Vol.105 (6), p.2316-2323 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.